Javier Fernández-Ruiz
Universidad Complutense de Madrid
H-index: 83
Europe-Spain
Top articles of Javier Fernández-Ruiz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice | Biomedicine & Pharmacotherapy | Claudia Gonzalo-Consuegra Irene Santos-García Laura García-Toscano Raquel Martín-Baquero Carmen Rodríguez-Cueto | 2024/5/1 |
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline | Aurora Semerano Javier Fernández-Ruiz Marta Cortes-Canteli María A Moro | 2024/1/10 | |
Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome | Neuropharmacology | Cristina Alonso Valentina Satta Inés Hernández-Fisac Javier Fernández-Ruiz Onintza Sagredo | 2023/6/7 |
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice | Journal of Neuroinflammation | Irene Santos-García Carmen Rodríguez-Cueto Patricia Villegas Fabiana Piscitelli Anna Lauritano | 2023/12 |
USE OF CANNABINOIDS IN THE TREATMENT OF DYSKINESIA ASSOCIATED WITH PARKINSON'S DISEASE | 2023/1/26 | ||
THE EFFICACY OF COMBINED TREATMENT WITH ΒETA-CARYOPHYLLENE AND CANNABIDIOL IN A MOUSE MODEL OF DRAVET SYNDROME | IBRO Neuroscience Reports | José Antonio Guimaré Ortiz Valentina Satta Álvaro Sierra Tarazona Cristina Alonso Gómez Ines Hernández-Fisac | 2023/10/1 |
Endocannabinoid-Binding Receptors as Drug Targets | María Gómez-Cañas Carmen Rodríguez-Cueto Valentina Satta Inés Hernández-Fisac Elisa Navarro | 2023 | |
EXPLORING THE MYELINATION STATUS IN A MURINE MODEL OF DRAVET SYNDROME | IBRO Neuroscience Reports | Valentina Satta Álvaro Sierra Tarazona José Antonio Guimaré Ortiz Ines Hernández-Fisac María Concepción García García | 2023/10/1 |
ANALYZING THE INFLUENCE OF CANNABIS SATIVA COMPOUNDS ON THE MYELINATION PROCESS IN A MURINE MODEL OF DRAVET SYNDROME | IBRO Neuroscience Reports | Álvaro Sierra Tarazona Valentina Satta José Antonio Guimaré Inés Hernández Fisac Javier Fernández Ruiz | 2023/10/1 |
The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy | Brain Sciences | Santiago Rodríguez-Carreiro Elisa Navarro Eduardo Muñoz Javier Fernández-Ruiz | 2023/8/31 |
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure–Activity Relationship | ACS Medicinal Chemistry Letters | Laura Figuerola-Asencio Paula Morales Pingwei Zhao Dow P Hurst Sommayah S Sayed | 2022/12/2 |
New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia | Biomolecules | Isabel Lastres-Becker Eva de Lago Ana Martínez Javier Fernández-Ruiz | 2022/8/29 |
P. 0357 Effect of a combination therapy with cannabidiol and β-caryophyllene in SCN1A-A1783V mice, an experimental model of dravet syndrome | European Neuropsychopharmacology | C Alonso Gómez V Satta I Hernández Fisac J Fernández Ruiz O Sagredo Ezkioga | 2021/12/1 |
Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease | European Journal of Pharmacology | José María Sánchez Montero Angel Agis-Torres David Solano Monica Söllhuber María Fernandez | 2021/3/15 |
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration | Acta neuropathologica communications | Marcos Galán-Ganga Carmen Rodríguez-Cueto Jesús Merchán-Rubira Félix Hernández Jesús Ávila | 2021/5/17 |
Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis | Carmen Rodríguez‐Cueto Laura García‐Toscano Irene Santos‐García Marta Gómez‐Almería Claudia Gonzalo‐Consuegra | 2021/3 | |
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis | Molecules | Sonia Burgaz Concepción García Claudia Gonzalo-Consuegra Marta Gómez-Almería Francisco Ruiz-Pino | 2021/12/16 |
(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice | Pharmacological Research | Isabel González-Mariscal Beatriz Carmona-Hidalgo Matthias Winkler Juan D Unciti-Broceta Alejandro Escamilla | 2021/7/1 |
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis | International Journal of Molecular Sciences | Marta Gómez-Almería Sonia Burgaz Carlos Costas-Insua Carmen Rodríguez-Cueto Irene Santos-García | 2021/1 |
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis | Brain Pathology | Carmen Rodríguez‐Cueto Marta Gómez‐Almería Laura García Toscano Julián Romero Cecilia J Hillard | 2021/5/13 |
